A Controlled Trial to Assess the Immunogenicity and Efficacy of Three Vaccine Dosing Strategies in HIV Infected Adults.

Trial Profile

A Controlled Trial to Assess the Immunogenicity and Efficacy of Three Vaccine Dosing Strategies in HIV Infected Adults.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 May 2017

At a glance

  • Drugs GSK 1536489A (Primary) ; Influenza virus vaccines
  • Indications Influenza A virus H1N1 subtype; Influenza A virus infections; Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 May 2016 Results of substudy assessing hemagglutination inhibition and microbead array assays published in the Vaccine.
    • 20 Aug 2010 Actual initiation date changed from Apr 2009 to Oct 2008 as reported by ClinicalTrials.gov.
    • 20 Aug 2010 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top